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We report the median cDNA viral load of norovirus
genogroup II is >100-fold higher than that of genogroup I in
the fecal specimens of patients with norovirus-associated
gastroenteritis. We speculate that increased cDNA viral
load accounts for the higher transmissibility of genogroup II
strains through the fecal-oral route.
N
orovirus (NoV), a member of the family Caliciviridae
in the genus Norovirus, is a major causative agent of
viral gastroenteritis, affecting all age groups worldwide
(1). NoVs are clustered into 5 genogroups; genogroup I
(GI), GII, and GIV infect humans (2). Molecular epidemi-
ologic studies in different countries and regions show that
NoV GII is the predominant genogroup circulating in the
community; it accounts for most sporadic, nosocomial,
and outbreak cases (3). However, its predominance cannot
be entirely explained. In this study, we show for the first
time that the median cDNAviral load of NoV GII is >100-
fold higher than that of GI in fecal specimens of patients
with NoV-associated gastroenteritis. This finding suggests
possible higher transmissibility of GII strains through the
fecal-oral route.
The Study
From December 2004 through November 2005, a total
of 651 fecal specimens were collected within 48 hours of
symptom onset from 627 patients (43.5% male, <1–97
years of age, 26.9% <16 years of age) with symptoms of
gastroenteritis at Prince of Wales Hospital, Hong Kong
Special Administrative Region, People’s Republic of
China. All cases were sporadic (defined as having no
known related cases). Fecal specimens were stored at
−70°C after collection and were processed in batches
monthly. Local monthly mean air temperature during the
study period was obtained from the Hong Kong
Observatory (available from http://www.hko.gov.hk/wxin-
fo/pastwx/ywx.htm).
Viral RNAwas purified from fecal specimens and tran-
scribed to cDNA as described (4). All specimens had a
detectable level of human β-actin cDNA, which suggests
high RNA integrity. Filter tips were used throughout the
study to minimize cross-contamination. NoV GI and GII
were detected by a quantitative and genogroup-specific
real-time PCR assay, as previously described (5). Sterile
water was used in place of cDNA as negative control.
Three amplicons from each genogroup were directly
sequenced to confirm their identities and genogroups on a
3100 Genetic Analyzer (Applied Biosystems, Foster City,
CA, USA). cDNA viral load was quantified in triplicate
per run against 10-fold serial dilutions (108–101 copies) of
external plasmid standards prepared by cloning
genogroup-specific amplicons into vector pCR2.1-TOPO
(Invitrogen Corp., Carlsbad, CA, USA). The lower detec-
tion limit of the assay was equivalent to 2 × 104 copies of
cDNA per gram of fecal specimen. Coefficients of varia-
tion within and between runs were calculated as the per-
centage of the ratio between the standard deviation and
mean of threshold cycle numbers from the standard curves.
The respective intra- and interassay coefficients of varia-
tion for NoV GI were 0%–4.1% and 1.9%–5.8%, respec-
tively, and 0.1%–6.1% and 2.7%–6.6%, respectively, for
NoV GII. These findings indicate the high reproducibility
in viral load quantitation by the assay. Two common gas-
troenteritis-associated viruses, sapovirus and group A
rotavirus, were detected in parallel, as previously
described (4,6).
Phylogenetic analysis of NoVisolates was performed by
using primer sets G1FF/G1SKR and G2FB/G2SKR for GI
and GII, respectively, as described elsewhere (7). Isolates
were clustered with the nomenclature system of Zheng et
al. (2). Since G1FF/G1SKR and G2FB/G2SKR completely
spanned the region amplified by the RT-PCR assay, the 2
primer sets were also used to check for sequence comple-
mentarity among target, primers, and probe used in quanti-
tation. Statistical analyses were performed by SPSS version
11.5.1 (SPSS Inc., Chicago, IL, USA), and figures were
constructed by Prism version 4.03 (GraphPad Software,
Inc., San Diego, CA, USA) and SPSS.
NoVs were detected in 54 (8.3%) fecal specimens.
Among the NoV-positive specimens, 8 (14.8%) were
infected with GI, 37 (68.5%) with GII, and 9 (16.7%) were
coinfected with GI and GII. Moreover, 3 (5.6%) specimens
were coinfected with sapovirus, 2 (3.7%) with group A
rotavirus, and 1 (1.9%) with sapovirus and group A
rotavirus. The mean age of patients infected with NoV GI
and GII was 54.6 and 33.0 years, respectively (p = 0.02).
Sex and hospitalization rates between patients infected
with the 2 genogroups did not differ significantly (Table).
The median cDNAviral load of NoVGI and GII detect-
ed in the fecal specimens was 8.4×105 (range 2.2×104 –
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per gram of fecal specimen (Figure 1A), respectively.
Although the range was comparable between the
genogroups, the median of NoV GII was >100-fold higher
than that of GI (p = 0.0022, 2-tailed Mann-Whitney U
test). Similar findings were obtained when NoV GI/GII
coinfections (p = 0.0066, Figure 1B) or all viral coinfec-
tions (p = 0.0042, Figure 1C) were excluded. Seven of 9
specimens with NoV GI/GII coinfections had higher
cDNA viral load of GII than GI, with fold changes from 4
to 452 (median 248) (Figure 2). Furthermore, while NoV
was detected year-round, a marked seasonal trend was evi-
dent: higher prevalence occurred in winter months, when
the cDNAviral load of GII was generally higher compared
with GI (online Appendix Figure 1, available from
http://www.cdc.gov/ncidod/EID/vol12no08/06-0081-
appG1.htm).
Multivariate linear regression model was used to deter-
mine the potential association between cDNA viral load,
NoV genogroup, and patient’s age. After age stratification,
the cDNAviral load in fecal specimen was still significant-
ly associated with NoV genogroup (β = 0.390, p = 0.002).
However, no significant association was found between
cDNA viral load and age of patients (β =  −0.060, p =
0.626).
Of the 63 NoV isolates, 43 (68.3%) were successfully
sequenced for phylogenetic analysis, including 7 GI and
36 GII isolates. NoV GI isolates covered at least 5 geno-
types, but no circulating strain predominated (online
Appendix Figure 2, http://www.cdc.gov/ncidod/EID/
vol12no08/06-0081-appG2.htm). For NoV GII isolates,
we found >8 genotypes; GII/4 was the most prevalent
(online Appendix Figure 3, http://www.cdc.gov/ncidod/
EID/vol12no08/06-0081-appG3.htm).
To rule out the possibility of a quantitation artifact due
to different stability between genogroups upon storage or
freeze-thaw cycle, viral RNAwas re-extracted and requan-
titated from a fecal specimen that had been stored for >6
months and coinfected with both NoV GI and GII. Repeat
testing showed no drop in cDNA viral load for either
genogroup, which suggests a comparable stability upon
storage. Sequence complementarity among target, primers,
and probe used in quantitation was also verified. While no
sequence mismatch in primers and probe was found among
the 7 NoV GI isolates, 5 of the 36 GII isolates had a single
mismatch. Thus, the low cDNA viral load of NoV GI
measured was unlikely due to sequence mismatching.
Conclusions
In this study, we show for the first time that the median
cDNA viral load of NoV GII is >100-fold higher than that
of GI in the fecal specimens of patients with NoV-associ-
ated gastroenteritis. Neither the possibility of quantitation
artifacts as a result of primers and probe mismatching nor
stability differences between genogroups on storage was
likely to account for our observation. Moreover, 7 of 9
specimens with NoV GI/GII coinfection exhibited higher
cDNA viral load of GII than that of GI. Also, the cDNA
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Figure 1. Scatterplots for cDNA viral load of noroviruses (NoV) genogroup I (GI) and GII. A) All positive isolates. B) All positive isolates,
excluding those with NoV GI/GII coinfection. C) All positive isolates, excluding all those with viral coinfection (NoV GI and GII together
with sapovirus, group A rotavirus, or both). The bars represent median cDNA viral loads. The p values were calculated by 2-tailed Mann-
Whitney U test.viral load of NoV GII was usually higher than that of GI
for each collection month, a finding that further supports
our interpretation.
We speculate that the increased cDNA viral load facili-
tates the transmission of NoV GII from infected persons to
susceptible hosts through the fecal-oral route. Studies on
other viruses have shown that viral load correlates well
with the epidemiology of diseases. For example, the pre-
dominance of HIV-1 over HIV-2 has been suggested to be
attributed to the higher viral load of HIV-1 (8). However,
the implication of viral shedding pattern and cDNA viral
load on epidemiologic characteristics and clinical manifes-
tations of NoVs deserves further investigation. Our find-
ings provide strong molecular evidence for the worldwide
predominance of NoV GII and may open new research
directions in the epidemiologic study of NoVs.
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Figure 2. cDNA viral load in 9 specimens with norovirus (NoV)
genogroup I (GI) and GII coinfection. 
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